Company
NxPrenatal
NX Prenatal provides an unprecedented level of insight into maternal and fetal health through a safe and convenient maternal blood testing approach.
Also known as NX Prenatal, NX Prenatal Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- Houston, TX, United States
- Customers
- physicians
- Legal name
- NX Prenatal Inc.
Record updated 28 September 2026
About
NX Prenatal Inc. is a private US-based molecular diagnostics company with its corporate headquarters in Houston, TX and Lexington, KY. NX Prenatal is developing diagnostic assays for adverse pregnancy conditions such as preterm birth, preeclampsia, and placenta accreta. It employs a proprietary exosome-based liquid biopsy platform, which enables advanced isolation and enrichment of exosome and microvesicle particles from bodily fluids for non-invasive biomarker evaluation. Our tests are designed to provide physicians an ideal opportunity to intervene in a timely manner with protocols for at-risk pregnancies in an attempt to reduce complications that can arise from adverse pregnancy outcomes for both the child and the mother.
Funding snapshot
- Total raised
- $8.6MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $3.1M2023-03-07
Funding rounds
- Round, 2023
- $3.1M2023-03-07, SEC form D sold, 20 investors
- Round, 2020
- $72K2020-11-16, SEC form D sold, 3 investors
- Round, 2020
- $5M2020-04-27, SEC form D sold, 47 investors
- Round, 2017
- $428K2017-09-20, SEC form D sold, 28 investors
Products
- Other
- Time2Prepare first-trimester blood test